Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Gsteiger

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 4, 2018
Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid ArthritisEva-Maria Didden, Yann Ruffieux, Noemi Hummel, et al.
Journal of Comparative Effectiveness Research|December 2, 2025
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysisSa Ren, Janharpreet Singh, Sandro Gsteiger, et al.
Lancet (London, England)|September 17, 2013
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trialDominique Baeten, Xenofon Baraliakos, Jürgen Braun, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 4, 2018
Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid ArthritisEva-Maria Didden, Yann Ruffieux, Noemi Hummel, et al.
Journal of Comparative Effectiveness Research|December 2, 2025
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysisSa Ren, Janharpreet Singh, Sandro Gsteiger, et al.
Lancet (London, England)|September 17, 2013
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trialDominique Baeten, Xenofon Baraliakos, Jürgen Braun, et al.
Pageof 3